Blog

Jemma Arakelyan: Radiation Oncologists’ expertise is needed for a crucial study on EGRT

Jemma Arakelyan/LinkedIn

Jan 18, 2025, 13:33

Jemma Arakelyan: Radiation Oncologists’ expertise is needed for a crucial study on EGRT

Jemma Arakelyan, Chief Executive Officer of The Institute of Cancer and Crisis, shared a post on LinkedIn:

“Calling all Radiation Oncologists! Your expertise is needed to contribute to a crucial study on Ethics-Guided Radiation Therapy (EGRT). Help us gather comprehensive information by sharing your valuable insights and experiences.

Global Perspective: This study aims to bring together voices from around the world to shape the future of radiation therapy practices.

Participate Now: Join us in this important initiative by completing the survey through the link.”

Dr. Jemma Arakelyan is a medical oncologist and the Chief Executive Officer of The Institute of Cancer and Crisis. Under her leadership, the Institute is dedicated to raising awareness and providing support for cancer patients facing critical challenges, including those arising from war and pandemics. Currently, she is pursuing her Ph.D. at the City University of Hong Kong, focusing on the development of new anticancer treatments and the mechanisms driving cancer progression.

In addition to her academic work, Dr. Arakelyan is actively involved in several scientific organizations, including the European School of Oncology (ESO), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). She also serves as an advisor at the Immune Oncology Research Institute, where they work closely on the clinical development of novel immunotherapeutic agents.

More posts featuring Jemma Arakelyan.